The Spine Journal
Volume 3, Issue 1 , Pages 87-88 , January 2003

To the Editor:

References 

  1. Schimandle JK, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine. 1995;20:1326–1327
  2. Boden SD, Martin GJ, Horton WC, Truss TL, Sandhu HS. Laparosocopic anterior spinal arthodesis with rhBMP-2 in a titanium threaded cage. J Spinal Dis. 1998;11:95–101
  3. Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg. 1995;77A:734–750
  4. Package insert, OP-1 Implant. Stryker Biotech, Hopkinton, MA.
  5. Package insert, In Fuse Bone Graft. Medtronic Sofamor Danek, Memphis, TN.
  6. Boden SD, Schimandle JH, Hutton WC. The use of osteoinductive growth factors for lumbar spinal fusion, part II (study of dose carrier and species). Spine. 1995;20:2633–2644
  7. Martin GJ, Boden SD, Morone MA, Moskovitz PA. Posterolateral intertransverse process spinal arthrodosis with rhBMP-2 in a nonhuman primate model (important lessons learned regarding dose, carrier and safety). J Spinal Dis. 1999;12:179–186
  8. Laursen M, Jay K, Hensen ES, Gellneck J, Christensen FB, Bunger CE. Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar bursts fractures in humans (preliminary results). Eur Spine J. 1999;8:485–490
  9. Urist MR, Hudak RT, Huo IK, Rasmussen JK. Osteoporosis (a bone morphogenetic protein auto-immune disorder). Prog Clin Biol Res. 1985;187:77–96

PII: S1529-9430(02)00573-9

The Spine Journal
Volume 3, Issue 1 , Pages 87-88 , January 2003